80 results
Page 3 of 4
8-K
EX-99.1
ov49pvl
19 May 21
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
zsp5wiebdgfl34
7 May 21
Business Highlights and 2021 Anticipated Milestones
7:00am
S-3ASR
0dx 0ug9w
2 Apr 21
Automatic shelf registration
4:59pm
8-K
EX-99.1
iv0mugim
18 Mar 21
Sutro Biopharma Reports Full Year 2020 Financial Results
7:00am
424B5
c08e8k7lli33hj
9 Dec 20
Prospectus supplement for primary offering
4:02pm
424B5
vcwt53 ouz5ph
7 Dec 20
Prospectus supplement for primary offering
4:10pm
8-K
EX-99.1
vlmdc
7 Dec 20
Regulation FD Disclosure
3:45pm
8-K
EX-99.1
0n1n vaz1vyso
4 Dec 20
Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
12:00am
8-K
EX-99.2
vtubu1pps3nqj
4 Dec 20
Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
12:00am
8-K
EX-99.1
2rw3uplse5bebbe968k
5 Nov 20
Sutro Biopharma Reports Third Quarter 2020 Financial Results
7:05am
8-K
EX-99.1
nwsxzp
9 Sep 20
Other Events
5:23pm
8-K
EX-99.1
r8k81v1re
6 Aug 20
Sutro Biopharma Reports Second Quarter 2020 Financial Results
7:03am
8-K
EX-99.1
gkd3pf7v58aftn
15 Jun 20
Regulation FD Disclosure
7:21am
424B5
a7rfgl
12 May 20
Prospectus supplement for primary offering
5:02pm
8-K
EX-99.1
krgnjmgy 1u43jekvvu
11 May 20
Sutro Biopharma Reports First Quarter 2020 Financial Results
4:27pm
424B5
hg5fafvnpmpu kus
11 May 20
Prospectus supplement for primary offering
4:12pm